Neuropathy in Amyloidosis – Amyloidosis Research Consortium
This booklet discusses the various impacts that amyloidosis may have on a patient’s nerves and potential management techniques.
Related Articles
FDA Grants Key Oncology Approvals and Designations in January 2025
Here is a look back on all the FDA happenings from the month of January 2025.
2024 Blood Journal Contest
9th Annual Blood Cover Art Contest is now open. In recognition of authors who published in Blood and images used in advancement of science, we…
Podcast: The Scope of US Medical Debt w/ Kinika Young | Health Affairs Podcast
Health Affairs’ Jeff Byers welcomes Kinika Young of The Leukemia & Lymphoma Society to the program to discuss a recent final rule/advisory issued by the…
January 2025 Early Career Newsletter – American Society for Radiation Oncology (ASTRO)
This issue includes important information on the committee’s initiatives for the upcoming year, including recording podcasts, organizing informal meetups at different society meetings, collaborating with…
Standard of care for frontline treatment of non-V600E-specific pLGG tumors
The experts in pediatric low-grade gliomas (pLGG) delineate the standard of care for frontline treatment of tumors not harboring the BRAF V600E mutation, outlining current…
Talquetamab Combo Data Warrant Further Research in R/R Multiple Myeloma
Findings from RedirecTT-1 show responses across different dose levels of talquetamab/teclistamab among those with multiple myeloma.
Podcast: The Scope of US Medical Debt w/ Kinika Young | Health Affairs Podcast
Health Affairs’ Jeff Byers welcomes Kinika Young of The Leukemia & Lymphoma Society to the program to discuss a recent final rule/advisory issued by the…
Fox Chase Cancer Center’s Dr. Eric Goodlev Named a Fellow of the American Academy of Hospice and Palliative Medicine
PHILADELPHIA (January 31, 2025) — Eric Goodlev, MD, an Associate Professor in the Supportive Oncology and Palliative Care Program at Fox Chase Cancer Center, was recently named…
George Santos Award — Editorial Award (Clinical Research) – Tandem Meetings News
Linde Morsink, MD, this year’s recipient of the Editorial Award for Clinical Research, previews her lecture on using post transplantation cyclophosphamide (PTCy) in combination with…
Pola-R-CHP Generates Long-Term PFS and DFS Advantages vs R-CHOP in Untreated DLBCL
Polatuzumab vedotin plus R-CHP improved PFS and DFS vs R-CHOP at 5 years in previously untreated patients with diffuse large B-cell lymphoma.